CSL Behring disclosed a “temporary global stockout” of its gene therapy for hemophilia B that it says could delay treatment for some patients. In a

AstraZeneca has added more details on how it will use its $15 billion budget to expand in China — and the UK pharma is betting

Pfizer said a combination of two of its prostate cancer drugs — Talzenna and Xtandi — succeeded in a Phase 3 study and that it

Eli Lilly has positive phase 3 results for its triple agonist retatrutide in diabetes to go with its earlier encouraging data in obesity.

Washington’s Medicaid program will start paying for a friendly AI-powered robot called ElliQ to keep seniors company and help them stay independent and healthy at